Meadows-Smith comes to AgraQuest following a 14-year career with Chemtura Corporation USA (formerly Crompton, Uniroyal Chemical and Great Lakes), where he recently served as Executive Vice President in charge of a $1.9 billion portfolio of businesses including the Crop Protection, Consumer Products, and Plastics Additives divisions. Prior to this, he was employed for six years by the Sumitomo Corporation where he was the Marketing Manager for the Crop Protection Products and Public Health Pesticides division, based out of London.
Meadows-Smith holds a degree in Biological Sciences, Genetics from the University of Birmingham in the United Kingdom and is a graduate of Harvard Business School’s Advanced Management Program.
Mike Miille joined AgraQuest as Chief Executive Officer and Chief Operating Officer in May of 2004. Previously, he was co-founder and COO of Sagres Discovery, a cancer therapeutics discovery company, where he was responsible for all aspects of operations and finance. Before Sagres, he was President and CEO of Zoogen, Inc. and Director and General Manager of Celera AgGen and Perkin Elmer Zoogen after they acquired Zoogen. At Zoogen, PE Zoogen and Celera AgGen, he led efforts to develop new markets which increased revenues by 300%. He expanded the company into the animal forensic market, and into plant genomics, which was spearheaded by the acquisition of Linkage Genetics and capped by award of a $20 million RhoBio contract.
Before AgGen and Zoogen, Dr. Miille was General Manager, Commercial Business, Quanterra (formed by merger of Enseco and IT) where he was responsible for 16 laboratories and $70M in revenues. Prior to that he worked in various management positions for Cal Analytical Labs, which later became Enseco.
Dr. Miille received a PhD in Agricultural and Environmental Chemistry from the University of California at Davis and a BS in Biological Sciences from Stanford.
Jung comes to AgraQuest with 14 years of experience as an executive in the life sciences and biotechnology industry, most recently as CFO of Celera Corporation where he led the finance and information technology groups in the spinoff of Celera from Applera Corporation. Prior to the spinoff, Jung served as Vice President, Finance at Applera Corporation for the Celera Group. Jung's background also includes working at Chiron Corporation for 11 years in several executive financial positions including V.P. & Treasurer and V.P., Finance for Chiron’s Blood Testing Division. He began his career at Varian Associates, Inc. and Bank of America in various financial management positions. Jung earned a Bachelor of Science in Aeronautical Engineering from Purdue University and holds an MBA from the Haas School of Business at the University of California, Berkeley.
Dr. Margolis brings over 19 years of management, business development and research experience from the innovative, results-driven biotech arena. Prior to joining AgraQuest, Jonathan Margolis was Senior Director of Chemical Genetics at Exelixes, Inc where he led a $100 million joint venture between Exelixis and Bayer CropScience, forged research alliances with Dow AgroSciences, and managed a large R & D department through periods of restructuring and rapid corporate growth. Jonathan is an internationally recognized expert on model systems in drug discovery, and an invited author and speaker at industry and public sector symposia. Dr. Margolis received a PhD in Biology from the University of California, San Diego and a BS in Biology from Swarthmore College.
Ashish Malik came to AgraQuest in April 2008 from Syngenta, where he served as the Head of Commercial Operations for the Home Care Division. During that time he was responsible for the overall leadership of the newly developed division, where he defined growth strategies, developed go-to-market approaches and identified opportunities for brand value building. Prior to his five-years with Syngenta, he worked for Imerys, where he was a Business Unit Director, and for BFGoodrich, where he served as a Market Manager. Mr. Malik holds an MBA with concentrations in Finance and Marketing from Carnegie Mellon University – Tepper School of Business, and a bachelor's degree in Engineering from Swarthmore College.
Ms. Huben comes to AgraQuest with 25 years of legal experience, most recently holding the position of Vice President and Associate General Counsel at Chemtura Corporation, a specialty chemical company, where she was responsible for global commercial and mergers and acquisitions activities. Prior to the formation of Chemtura, she spent seven years with Chemtura predecessor companies, working out of offices in Connecticut, London and Geneva. Before that time, Ms. Huben was General Counsel & Secretary of EnviroSource, Inc. Her vast professional experience includes leading large and small corporations through a variety of commercial legal matters including mergers and acquisitions, joint ventures, product distribution arrangements, corporate finance, corporate governance, and compliance programs. Ms. Huben holds a J.D from Pace University School of Law and a B.A from the State University of New York at Albany.
Mr. Lamonega, a seasoned agriculture professional with more than 35 years experience, joined AgraQuest in July of 2009. With his wealth of international experience, as well as proven success in launching products and growing businesses during his 30 years at Chemtura (Uniroyal/Crompton), Lamonega was originally tasked with building the Latin American organization and developing the Asia business for AgraQuest. More recently, he was assigned responsibility for North American Sales. He will head an experienced team committed to growing AgraQuest's position as the world leader in innovative low chemical solutions. A native of Argentina, Lamonega relocated from Sao Paulo, Brazil to Davis, California. He holds a B.S. degree in Agricultural Engineering from La Plata University in Argentina.
Board of Directors
John Pasquesi, MBA,Otter Capital was founded by John Pasquesi to make a variety of private equity investments. Prior to founding Otter Capital, Mr. Pasquesi was a Managing Director and member of the Executive Committee of Hellman & Friedman LLC, a private equity investment firm that has raised and managed over $4.8 billion of committed capital. Prior to joining Hellman & Friedman in 1987, Mr. Pasquesi was associated with Golder, Thoma & Cressey, a Chicago based private equity firm. Mr. Pasquesi has an MBA from Stanford.
Edward Forwood, MD, of Loudwater Investment Partners, has had a 20 year career in managing, advising and investing in technology and other early stage companies. Prior to that, he trained in corporate finance at Hill Samuel Bank Limited and Ernst & Young, having qualified as a Chartered Accountant with KPMG. He was the founding chief executive of kVault Software Limited which was sold in 2004 for $225 million. Edward spent seven years at Durlacher, latterly as Director of Private Equity. Prior to working at Durlacher, Edward co-lead two management buy-ins of technology and engineering companies. He has an MA degree in law from Cambridge University.
Martin Huml is a Managing Partner and the founder of Runway Capital LLC, a private equity investment firm. Prior, Martin founded and ran a consulting business which advised venture capital firms on their portfolio companies; his clients included Mayfield, Soros, Norwest, Weisel, JPMorgan CP, Oak, NEA, TCV, Bain Capital, and Pequot. Before Runway, he worked in the Private Equity group of Credit Suisse First Boston in London for four years. Martin started his business career as an entrepreneur founding, running and successfully selling a company which became the exclusive Apple Computer distributor for most of Central and Eastern Europe including Russia and Czechoslovakia. He graduated with honors with a M.S. in Electrical Engineering and Computer Science from the Czech Technical University, Prague, Czech Republic and holds a postgraduate degree in Finance from Stern Graduate School of Business, New York University.
Martin serves as Chairman of Arena Solutions and Chairman of Konsepti.
Gina Domanig is the Managing Partner of Emerald Technology Ventures based in Zurich, Switzerland. In 2000, she founded Emerald as the first independent cleantech venture capital fund in Europe. Emerald is one of the largest dedicated cleantech funds and the first with a transatlantic strategy. Gina also currently serves on the boards of SDCmaterials, TaKaDu, SynapSense and Pelamis Wave Power. Gina has over 25 years of international business experience including banking, M&A, strategic development, and venture capital. Prior to starting Emerald, she was senior vice president at Sulzer, a Swiss multinational, responsible for strategic planning and M&A. During her ten year tenure, she built up a team which completed 45 transactions including acquisitions, divestitures, IPOs and JVs in industrial technology sectors. Gina holds MBA degrees from Thunderbird in Arizona and ESADE in Barcelona and is fluent in English, German and Spanish.
Managing Director of TPG Ventures since 2004, Mr. Mclashan previously served as Chairman and CEO of Critical Path since April of 2001.
Prior to that, he served as chief executive of technology investment firm Vectis Group LLC and as a Venture Partner at Whitney & Co., the first established venture firm in the U.S., with approximately $5 billion under management. Before that he co-founded and served as president of Pharmanex, a leading phyto-pharmaceutical and dietary supplement company.
Prior to Pharmanex, McGlashan was co-founder and CEO of Generation Ventures, a firm funded by Whitney & Co. that started new ventures and facilitated the entry of U.S. technology companies in China. He also co-founded and served as president of TRADE Inc., a venture funded trade information database company, and was a senior associate with Bain Capital and Information Partners.
McGlashan earned a Bachelor of Arts degree in history at Yale University and a master's degree in business administration from the Stanford Graduate School of Business.
Mark Wong specializes in technology integration and commercialization and has 35 years of experience in agribusiness and biofuels. His experience includes operations management, technology assessment, business acquisition and divestiture, workouts, and international business.
Currently Mark is CEO of Agrivida Inc. which is a privately held biotechnology company focused on the production of cheap sugars from plant biomass. He is also Non-Executive Chairman of the Board of BioFuel Energy Corporation which is a publicly traded corn ethanol company.
Mark was CEO of Operations and founder of Emergent Genetics, Inc. After growing the business for seven years, Mark and his partnering investors successfully sold the business to Monsanto Company, earnings increased five-fold during the seven years of operation. At the time of sale, the Company was the second largest cotton seed company on in the world and had integrated Monsanto genes for insect resistance and herbicide tolerance into its seed lines.
Mark is also the founder of Consus Corporation Inc., a private venture-investment and management-advisory firm that specializes in the agricultural biotechnology and biofuels sectors. His activities in these areas include participation in founding and management of over a dozen companies in agricultural biotechnology and biofuels. Mark’s companies have had an exit value of approximately $900 million to date.
Mark has held various management positions with FMC, including General Manager of the Niagara Seed Division. He served as Chief Operating Officer of Agrigenetics Corporation and subsequently was President and Chief Executive Officer of Agracetus Corporation, a subsidiary of W.R. Grace & Company. He is Chairman of the Board of Industrial Laboratories, Inc., a private food testing company.
Mark holds a B.S. in Chemical Engineering from Lehigh University, and a M.B.A. from The Wharton School of Finance. Mark is based in Boulder, Colorado.
Mr. Shapiro is the co-founder and Managing Director of Sandbox Industries. He was formerly Chairman and CEO of Monsanto Company and served as Chairman of the Pharmacia Corporation.
Previously, Bob was President of Monsanto’s Agriculture Group, Chairman and CEO of The NutraSweet Company (a subsidiary of Monsanto), and President of the NutraSweet Group of G.D.Searle & Co., where he previously served as Vice President and General Counsel. Before joining Searle, Bob was Vice President and General Counsel of General Instrument Corporation. Prior to this, he practiced law in New York City; served in government as Special Assistant to the Undersecretary of the U.S Department of Transportation; and as a professor of law at Northeastern University in Boston and the University of Wisconsin in Madison.
Bob has served on the boards of the New York Stock Exchange (later NYSE Euronext), Citigroup, Rockwell International, Silicon Graphics, and Sequus Pharmaceuticals. He currently serves as a director of Theranos, Inc., Sapphire Energy, Inc., and Elevance Renewable Sciences.
He has also served on the President’s Advisory Committee on Trade Policy and on the White House Domestic Policy Review of Industrial Innovation. He is a Fellow of the American Academy of Arts and Sciences.
Bob is a 1959 graduate of Harvard College and holds a JD from Columbia University School of Law.